Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Aeglea Biotherapeutics Inc. (AGLE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,652,260 $21,351 +5% 0.66%
2.
OrbiMed Advisors

Samuel Isaly

2,165,524 $17,432 0.26%
3.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

800,000 $6,440 +24% 0.24%
4.
Deerfield Management

James E. Flynn

500,046 $4,025 0.15%
5.
Baker Bros. Advisors

Julian Baker And Felix Baker

1,713,604 $13,795 0.08%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.23 5,282 Officer, Director 353,643 2019-06-14 Filing
$6.17 14,406 Officer, Director 348,361 2019-06-13 Filing
$6.11 12,217 Officer, Director 333,955 2019-06-12 Filing
$6.86 3,809 Officer, Director 321,738 2019-05-22 Filing
$6.89 13,794 Officer, Director 317,929 2019-05-21 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.50 5,900 Officer 2,500 2018-09-27 Filing
$9.55 100 Officer 8,400 2018-09-27 Filing
$10.06 19,550 2,175,314 2018-05-11 Filing
$10.13 22,725 2,194,864 2018-05-10 Filing
$10.11 51,230 2,217,589 2018-05-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,220,911 $9,828 7.48%
2. 335,279 $2,699 3.43%
3. 271,542 $2,186 2.06%
4. 240,500 $1,934 1.73%
5. 975,000 $7,849 0.72%
News See All